Peripherally injected canabidiol reduces neuropathic pain in mice: Role of the 5-HT1A and TRPV1 receptors
Biochemical and Biophysical Research Communications · 2023
DOI: 10.1016/j.bbrc.2023.04.022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023. Verfasst von Danielle Diniz Aguiar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Institute of Biological Sciences, UFMG, Belo Horizonte, MG, Brazil. Hauptthemen laut MEDLINE: Cannabidiol, Neuralgia. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Council for Scientific and Technological Development.
Abstract (Originalsprache)
Cannabidiol (CBD) is the most abundant non-psychoactive component found in plants of the genus Cannabis. Its analgesic effect for the treatment of neuropathy has been widely studied. However, little is known about its effects in the acute treatment when Cannabidiol is administered peripherally. Because of that, this research was aimed to evaluate the antinociceptive effects of the CBD when administered peripherally for the treatment of acute neuropathic pain and check the involvement of the 5-HT1A and the TRPV1 receptors in this event. Neuropathic pain was induced with the constriction of the sciatic nerve while the nociceptive threshold was measured using the pressure test of the mouse paw. The technique used proved to be efficient to induce neuropathy, and the CBD (5, 10 and 30 μg/paw) induced the antinociception in a dosage-dependent manner. The dosage used that induced a more potent effect (30 μg/paw), did not induce a systemic response, as demonstrated by both the motor coordination assessment test (RotaRod) and the antinociceptive effect restricted to the paw treated with CBD. The administration of NAN-190 (10 μg/paw), a selective 5-HT1A receptor antagonist, and SB-366791 (16 μg/paw), a selective TRPV1 antagonist, partially reversed the CBD-induced antinociception. The results of the research suggest that the CBD produces the peripheral antinociception during the acute treatment of the neuropathic pain and it partially involved the participation of the 5-HT1A and TRPV1 receptors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Institute of Biological Sciences, UFMG, Belo Horizonte, MG, Brazil.
- Department of Pharmacology, School of Medicine of Ribeirão Preto, USP, Ribeirão Preto, SP, Brazil.
- Department of Pharmacology, Institute of Biological Sciences, UFMG, Belo Horizonte, MG, Brazil. Electronic address: thiromero@ufmg.br.
Förderung
- National Council for Scientific and Technological Development
Zitieren
APA
Aguiar, D. D., da Costa Oliveira, C., Fonseca, F. C. S., de Almeida, D. L., Campos Pereira, W. V., Guimarães, F. S., Perez, A. C., Duarte, I. D. G., & Romero, T. R. L. (2023). Peripherally injected canabidiol reduces neuropathic pain in mice: Role of the 5-HT1A and TRPV1 receptors. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.04.022
Vancouver
Aguiar DD, da Costa Oliveira C, Fonseca FCS, de Almeida DL, Campos Pereira WV, Guimarães FS, et al. Peripherally injected canabidiol reduces neuropathic pain in mice: Role of the 5-HT1A and TRPV1 receptors. Biochemical and Biophysical Research Communications. 2023. doi:10.1016/j.bbrc.2023.04.022
BibTeX
@article{Aguiar2023,
author = {Aguiar, Danielle Diniz and da Costa Oliveira, Cristina and Fonseca, Flávia Cristina Sousa and de Almeida, Douglas Lamounier and Campos Pereira, William Valadares and Guimarães, Francisco Silveira and Perez, Andrea Castro and Duarte, Igor Dimitri Gama and Romero, Thiago Roberto Lima},
title = {Peripherally injected canabidiol reduces neuropathic pain in mice: Role of the 5-HT1A and TRPV1 receptors},
journal = {Biochemical and Biophysical Research Communications},
year = {2023},
doi = {10.1016/j.bbrc.2023.04.022}
}
EUVIMED